发明名称 N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
摘要 The present invention relates to an improved and shortened synthesis of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acet-amide and the mesylate monohydrate salt thereof by using boronic acid derivatives or borolane reagents while avoiding toxic organic tin compounds and to the mesylate monohydrate salt of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acet-amide which has demonstrated increased long term stability and release kinetics from pharmaceutical compositions.
申请公布号 US9340535(B2) 申请公布日期 2016.05.17
申请号 US201214347287 申请日期 2012.09.26
申请人 AICURIS GMBH & CO. KG 发明人 Schwab Wilfried;Birkmann Alexander;Vogtli Kurt;Haag Dieter;Lender Andreas;Grunenberg Alfons;Keil Birgit;Rehse Joachim
分类号 C07D417/12 主分类号 C07D417/12
代理机构 Millen White Zelano and Branigan, PC 代理人 Millen White Zelano and Branigan, PC ;Henter Csaba;Zelano Anthony
主权项 1. A crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]acetamide methanesulfonic acid monohydrate having a purity above 96 weight-%.
地址 Wuppertal DE